Prosight Management »

Onkure Therapeutics Inc-a shares owned by Prosight Management

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Prosight Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $737k 268k 2.75
2025-06-30 $382k 160k 2.39
2025-03-31 $802k 187k 4.30
2024-12-31 $548k 64k 8.60

More positions owned by Prosight Management

Galapagos Nv Spon Adr (GLPG)
Meiragtx Holdings (MGTX)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Intuitive Surgical Com New (ISRG)
Janux Therapeutics (JANX)
Roivant Sciences SHS (ROIV)
Icon SHS (ICLR)
Syndax Pharmaceuticals (SNDX)
Bridgebio Pharma (BBIO)
Crinetics Pharmaceuticals In (CRNX)
Amicus Therapeutics (FOLD)
Dex (DXCM)
Shattuck Labs (STTK)
Zymeworks Del (ZYME)

View all positions for Prosight Management

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
Shay Capital
Vanguard Group
Highbridge Capital Management
Vestal Point Capital
BlackRock
StepStone
Cantor Fitzgerald, L. P.
NEA Management Company
Carlyle
Prosight Management
Renaissance Technologies
Rangeley Capital
Tang Capital Management

View all funds holding Onkure Therapeutics Inc-a